CoChat
Sign Up
Cited by 293Coffee research and impactsNatural Antidiabetic Agents StudiesDiet, Metabolism, and Disease

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Acute Effects of Decaffeinated Coffee and the Major Coffee Components Chlorogenic Acid and Trigonelline on Glucose Tolerance

Open access
van Dijk, Aimée E., Olthof, Margreet R., Meeuse, Joke C., Seebus, Elin, Heine, Rob J., van Dam, Rob M.·2009·Diabetes Care
DOI 10.2337/dc09-0207PMC PMC2681030
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: Coffee consumption has been associated with lower risk of type 2 diabetes. We evaluated the acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. RESEARCH DESIGN AND METHODS: We conducted a randomized crossover trial of the effects of 12 g decaffeinated coffee, 1 g chlorogenic acid, 500 mg trigonelline, and placebo (1 g mannitol) on glucose and insulin concentrations during a 2-h oral glucose tolerance test (OGTT) in 15 overweight men. RESULTS: Chlorogenic acid and trigonelline ingestion significantly reduced glucose (−0.7 mmol/l, P = 0.007, and −0.5 mmol/l, P = 0.024, respectively) and insulin (−73 pmol/l, P = 0.038, and −117 pmol/l, P = 0.007) concentrations 15 min following an OGTT compared with placebo. None of the treatments affected insulin or glucose area under the curve values during the OGTT compared with placebo. CONCLUSIONS: Chlorogenic acid and trigonelline reduced early glucose and insulin responses during an OGTT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-0207

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 15 references

Cited by

Sorted by citations

Items 201–293 of 293

Related

See all

Metadata

Authors
van Dijk, A. E., Olthof, M. R., Meeuse, J. C., Seebus, E., Heine, R. J., & van Dam, R. M.
Affiliations
  • Department of Health Sciences and the EMGO Institute for Health and Care Research, VU University Amsterdam, the Netherlands;
  • Amsterdam Public Health (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts;
Corresponding author
Olthof, Margreet R.
ORCID
Olthof, Margreet R.
Venue
Diabetes Care
Publisher
American Diabetes Association
Published
2009-02-24
Volume
32
Issue
6
Pages
1023-1025
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
DOI
10.2337/dc09-0207
PMC
PMC2681030
OpenAlex
W2151356634
Cited by
293
References
15
Citations by year
2026: 4 · 2025: 11 · 2024: 7 · 2023: 16 · 2022: 22 · 2021: 21 · 2020: 24 · 2019: 15 · 2018: 24 · 2017: 21 · 2016: 19 · 2015: 17 · 2014: 21 · 2013: 22 · 2012: 17
FWCI
11.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Vrije Universiteit Amsterdam
  • Diabetes Fonds
  • National Center for Advancing Translational Sciences (L30 TR001051)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
decaffeinated coffee, chlorogenic acid, trigonelline, glucose tolerance, insulin response, type 2 diabetes risk, oral glucose tolerance test, overweight men
MeSH terms
Alkaloids, Blood Glucose, Caffeine, Chlorogenic Acid, Coffee, Glucose Tolerance Test, Humans, Insulin, Male, Mannitol, Placebos, Cross-Over Studies, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review